Researchers conducted a retrospective study using data from 182 subjects with high-risk recurrent prostate cancers.

Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Penile Cancer.

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

The AP reported that Netanyahu is expected to remain in the hospital for several days. According to Johns Hopkins Medicine, it is recommended not to perform strenuous activity or heavy lifting for at ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Researchers at UCLA have unveiled startling findings using PSMA-PET imaging that reveal nearly half of patients diagnosed ...

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment.

Nearly a quarter of all new cancer cases may have been missed during the Covid pandemic, a World Health Organisation (WHO) ...

Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

Hundreds of Australians with breast and prostate cancer will benefit from new treatments being added to the Pharmaceutical ...